Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity

Hsuan-Yuan Wang1,2, Sarah M Valencia2, Susanne P Pfeifer3

  • 1Department of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.

Viruses
|July 2, 2021
PubMed

Insights

Human cytomegalovirus (HCMV) genetic variations in glycoproteins are common and impact disease severity. Understanding these polymorphisms and their geographic distribution is crucial for developing effective vaccines and antiviral therapies against HCMV.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Human cytomegalovirus (HCMV) is a widespread virus causing significant illness and death in immunocompromised individuals.
  • Mixed strain HCMV infections are increasingly observed and linked to more severe disease outcomes.
  • The complexity of the HCMV genome necessitates a population-level perspective on its genetic evolution.

Purpose of the Study:

  • To review common polymorphisms in HCMV glycoproteins.
  • To compare variable regions and summarize geographic distributions of HCMV genetic variants.
  • To discuss strain-specific immunity, including neutralization and cellular immunity, in the context of HCMV glycoprotein variation.

Main Methods:

  • Review of frequently sampled polymorphisms in HCMV glycoproteins.
  • Comparative analysis of variable glycoprotein regions.
  • Summarization of observed geographic distributions of HCMV strains.
  • Discussion of immunological data related to strain-specific immunity.

Main Results:

  • Identification of frequently sampled polymorphisms in HCMV glycoproteins.
  • Characterization of variable regions within these glycoproteins.
  • Compilation of geographic distribution data for different HCMV genetic variants.
  • Discussion of the implications of genetic variation for strain-specific immunity.

Conclusions:

  • Genetic variation in HCMV glycoproteins is significant and influences disease.
  • Understanding geographic distribution of HCMV strains is vital for public health.
  • The identified genetic variations provide a valuable resource for future HCMV vaccine and antiviral drug development.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
849
Cross-reactivity00:42

Cross-reactivity

Overview
31.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.1K